Likewise, as a transcript factor, WT1 recruits TET2 to epigenetically activate target genes by demethylation (63), and mutant WT1 was evidenced to produce DNA hypermethylation in the AML cell line, typically targeting polycomb repressor complex 2 (PRC2) (55). The gene discussed is TET2; the disease is acute myeloid leukemia.